Neil joined the Life Sciences team at Canaccord in 2006 after several years in the biotechnology sector. Prior, Neil worked as an associate analyst covering both small and large-cap biotech and pharmaceutical companies. Neil began his career as an Investment Analyst at MDS Capital, one of the largest biotechnology-focused venture capital management firms in Canada. Neil graduated with an undergraduate degree in Life Sciences and a Masters degree in Physiology and Molecular Biology from Queen's University in Kingston, Ontario. He also holds an MBA from the Richard Ivey School of Business at the University of Western Ontario.